ANTI-TUMOR AGENT

ANTI-TUMOR AGENT

An object of the present invention is to provide an anti-tumor agent that exhibits a remarkably excellent anti-tumor effect. According to the present invention, there is provided an anti-tumor agent for curing cancer, the anti-tumor agent having a liposome which has an inner water phase and having a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: MATSUMOTO, Takeshi, NAKAYAMA, Shinji, KIMURA, Toshifumi, MOROHASHI, Yasushi, SUZUKI, Keiko, MORI, Mikinaga, SHIMOYAMA, Susumu
Format: Patent
Sprache:eng
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator MATSUMOTO, Takeshi
NAKAYAMA, Shinji
KIMURA, Toshifumi
MOROHASHI, Yasushi
SUZUKI, Keiko
MORI, Mikinaga
SHIMOYAMA, Susumu
description An object of the present invention is to provide an anti-tumor agent that exhibits a remarkably excellent anti-tumor effect. According to the present invention, there is provided an anti-tumor agent for curing cancer, the anti-tumor agent having a liposome which has an inner water phase and having an aqueous solution which is an outer water phase and disperses the liposome, in which the liposome encompasses topotecan or a salt thereof, a lipid constituting the liposome contains a lipid modified with polyethylene glycol, dihydrosphingomyelin, and cholesterol, the inner water phase contains an ammonium salt, and the topotecan or the salt thereof encompassed in the liposome is administered at a dose rate of 0.1 mg/m2 body surface area to 10 mg/m2 body surface area, in terms of topotecan per administration.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US2024099975A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US2024099975A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US2024099975A13</originalsourceid><addsrcrecordid>eNrjZBBw9Avx1A0J9fUPUnB0d_UL4WFgTUvMKU7lhdLcDMpuriHOHrqpBfnxqcUFicmpeakl8aHBRgZGJgaWlpbmpo6GxsSpAgB6Ch6I</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>ANTI-TUMOR AGENT</title><source>esp@cenet</source><creator>MATSUMOTO, Takeshi ; NAKAYAMA, Shinji ; KIMURA, Toshifumi ; MOROHASHI, Yasushi ; SUZUKI, Keiko ; MORI, Mikinaga ; SHIMOYAMA, Susumu</creator><creatorcontrib>MATSUMOTO, Takeshi ; NAKAYAMA, Shinji ; KIMURA, Toshifumi ; MOROHASHI, Yasushi ; SUZUKI, Keiko ; MORI, Mikinaga ; SHIMOYAMA, Susumu</creatorcontrib><description>An object of the present invention is to provide an anti-tumor agent that exhibits a remarkably excellent anti-tumor effect. According to the present invention, there is provided an anti-tumor agent for curing cancer, the anti-tumor agent having a liposome which has an inner water phase and having an aqueous solution which is an outer water phase and disperses the liposome, in which the liposome encompasses topotecan or a salt thereof, a lipid constituting the liposome contains a lipid modified with polyethylene glycol, dihydrosphingomyelin, and cholesterol, the inner water phase contains an ammonium salt, and the topotecan or the salt thereof encompassed in the liposome is administered at a dose rate of 0.1 mg/m2 body surface area to 10 mg/m2 body surface area, in terms of topotecan per administration.</description><language>eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20240328&amp;DB=EPODOC&amp;CC=US&amp;NR=2024099975A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20240328&amp;DB=EPODOC&amp;CC=US&amp;NR=2024099975A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>MATSUMOTO, Takeshi</creatorcontrib><creatorcontrib>NAKAYAMA, Shinji</creatorcontrib><creatorcontrib>KIMURA, Toshifumi</creatorcontrib><creatorcontrib>MOROHASHI, Yasushi</creatorcontrib><creatorcontrib>SUZUKI, Keiko</creatorcontrib><creatorcontrib>MORI, Mikinaga</creatorcontrib><creatorcontrib>SHIMOYAMA, Susumu</creatorcontrib><title>ANTI-TUMOR AGENT</title><description>An object of the present invention is to provide an anti-tumor agent that exhibits a remarkably excellent anti-tumor effect. According to the present invention, there is provided an anti-tumor agent for curing cancer, the anti-tumor agent having a liposome which has an inner water phase and having an aqueous solution which is an outer water phase and disperses the liposome, in which the liposome encompasses topotecan or a salt thereof, a lipid constituting the liposome contains a lipid modified with polyethylene glycol, dihydrosphingomyelin, and cholesterol, the inner water phase contains an ammonium salt, and the topotecan or the salt thereof encompassed in the liposome is administered at a dose rate of 0.1 mg/m2 body surface area to 10 mg/m2 body surface area, in terms of topotecan per administration.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2024</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZBBw9Avx1A0J9fUPUnB0d_UL4WFgTUvMKU7lhdLcDMpuriHOHrqpBfnxqcUFicmpeakl8aHBRgZGJgaWlpbmpo6GxsSpAgB6Ch6I</recordid><startdate>20240328</startdate><enddate>20240328</enddate><creator>MATSUMOTO, Takeshi</creator><creator>NAKAYAMA, Shinji</creator><creator>KIMURA, Toshifumi</creator><creator>MOROHASHI, Yasushi</creator><creator>SUZUKI, Keiko</creator><creator>MORI, Mikinaga</creator><creator>SHIMOYAMA, Susumu</creator><scope>EVB</scope></search><sort><creationdate>20240328</creationdate><title>ANTI-TUMOR AGENT</title><author>MATSUMOTO, Takeshi ; NAKAYAMA, Shinji ; KIMURA, Toshifumi ; MOROHASHI, Yasushi ; SUZUKI, Keiko ; MORI, Mikinaga ; SHIMOYAMA, Susumu</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US2024099975A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2024</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>MATSUMOTO, Takeshi</creatorcontrib><creatorcontrib>NAKAYAMA, Shinji</creatorcontrib><creatorcontrib>KIMURA, Toshifumi</creatorcontrib><creatorcontrib>MOROHASHI, Yasushi</creatorcontrib><creatorcontrib>SUZUKI, Keiko</creatorcontrib><creatorcontrib>MORI, Mikinaga</creatorcontrib><creatorcontrib>SHIMOYAMA, Susumu</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>MATSUMOTO, Takeshi</au><au>NAKAYAMA, Shinji</au><au>KIMURA, Toshifumi</au><au>MOROHASHI, Yasushi</au><au>SUZUKI, Keiko</au><au>MORI, Mikinaga</au><au>SHIMOYAMA, Susumu</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>ANTI-TUMOR AGENT</title><date>2024-03-28</date><risdate>2024</risdate><abstract>An object of the present invention is to provide an anti-tumor agent that exhibits a remarkably excellent anti-tumor effect. According to the present invention, there is provided an anti-tumor agent for curing cancer, the anti-tumor agent having a liposome which has an inner water phase and having an aqueous solution which is an outer water phase and disperses the liposome, in which the liposome encompasses topotecan or a salt thereof, a lipid constituting the liposome contains a lipid modified with polyethylene glycol, dihydrosphingomyelin, and cholesterol, the inner water phase contains an ammonium salt, and the topotecan or the salt thereof encompassed in the liposome is administered at a dose rate of 0.1 mg/m2 body surface area to 10 mg/m2 body surface area, in terms of topotecan per administration.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_US2024099975A1
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title ANTI-TUMOR AGENT
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T20%3A25%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=MATSUMOTO,%20Takeshi&rft.date=2024-03-28&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS2024099975A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true